The offer divided into three parts. Targeted to institutions, to the public in Sweden and to the public in Finland.

The company issues 3 937 007 shares.

Rights issue. Pre-emptive right 14:1. A subscription right is obtained for each share. Each subscription right entitles to subscription of fourteen (14) new shares. For each two (2) subscribed and paid shares, one (1) subscription option is also received.

The company issues 45 552 444 shares. The issue is guaranteed 20.6 per cent.

Determined by the VWAP 2) of the Company’s share on First North Finland between 7 Oct - 18 Oct 2019, with and applied discount of 25 per cent.

The subscription price is, however, at least €0.115.

Read the full Nexstim press release about this event

The Offer Warrants have been secured to 100 per cent by the Underwriters, totalling to approximately EUR 1.8 million in proceeds (excluding applicable fees and expenses). Subscription commitments equalling approximately 26 per cent of the Offer Warrants have been secured from existing shareholders and underwriting commitments equalling approximately 74 per cent of the Offer Warrants have been secured from current shareholders and external investors.

Subscription commitments of approximately EUR 0.5 million have been received from the Company’s largest holders of the Offer Warrants Kaikarhenni Oy, Ossi Haapaniemi, Kalksten Properties Koy and Capricorn Health-tech Fund as well as members of the Board of Directors and management of the Company holding such Offer Warrants.

Determined by the VWAP 2) of the Company’s share on First North Finland between 7 Oct - 18 Oct 2019, with and applied discount of 25 per cent.

The subscription price is, however, at least €0.115 per share or SEK 1.24

Read the full Nexstim Oyj press release about this event

The Offer Warrants have been secured to 100 per cent by the Underwriters, totalling to approximately EUR 1.8 million in proceeds (excluding applicable fees and expenses). Subscription commitments equalling approximately 26 per cent of the Offer Warrants have been secured from existing shareholders and underwriting commitments equalling approximately 74 per cent of the Offer Warrants have been secured from current shareholders and external investors.

Subscription commitments of approximately EUR 0.5 million have been received from the Company’s largest holders of the Offer Warrants Kaikarhenni Oy, Ossi Haapaniemi, Kalksten Properties Koy and Capricorn Health-tech Fund as well as members of the Board of Directors and management of the Company holding such Offer Warrants.

Each shareholder of Nexstim receives one (1) book-entry subscription right which entitles to subscribe Offer Shares ("Subscription Right") against each of the Company's share held by a shareholder on 6 May 2020 ("Record Date"). Each one (1) Subscription Right grants a right to subscribe for six (6) Offer Shares at the subscription price of EUR 0.006 per Offer Share ("Subscription Price"). The Subscription Price for the Offer Shares that are registered with Euroclear Sweden and listed on the First North Sweden marketplace which is maintained by Nasdaq Stockholm AB, is 0.06 SEK per Offer Share.

The company issues 376 719 780 shares. Company’s major shareholders, Capricorn Healthtech Fund, Kaikarhenni Oy and Ossi Haapaniemi with his related-party companies, and the Company’s management team and certain Board members are, subject to certain terms and conditions, committed to subscribing for approximately 28% of the Offer Shares of the amount of approximately EUR 0.634 million.

Read the full Nexstim press release about this event

The offer divided into three parts. Targeted to institutions, to the public in Sweden and to the public in Finland.

The company issues 3 937 007 shares.

Directed issue, to institutions via an accelerated book building process.

On December 16, 2015, Nexstim announced that they are making a targeted issue through an accelerated book building process aimed to the institutional investors. The Company intends to offer up to approximately 850,000 shares.

The Company received subscriptions for 880,000 shares which brings to the company € 5,280,000.

Directed issue of new shares to a London-based fund managed by City Financial Investment Company Limited.

The company issues 7 000 000 shares.

Targeted to Capricorn Health-tech Fund.

The company issues 4 000 000 shares.

Rights issue. Pre-emptive right 14:1. A subscription right is obtained for each share. Each subscription right entitles to subscription of fourteen (14) new shares. For each two (2) subscribed and paid shares, one (1) subscription option is also received.

The company issues 45 552 444 shares. The issue is guaranteed 20.6 per cent.

Directed issue.

The company issues 15 761 416 shares.

Read the full Nexstim Oyj press release about this event

Each shareholder of Nexstim receives one (1) book-entry subscription right which entitles to subscribe Offer Shares ("Subscription Right") against each of the Company's share held by a shareholder on 6 May 2020 ("Record Date"). Each one (1) Subscription Right grants a right to subscribe for six (6) Offer Shares at the subscription price of EUR 0.006 per Offer Share ("Subscription Price"). The Subscription Price for the Offer Shares that are registered with Euroclear Sweden and listed on the First North Sweden marketplace which is maintained by Nasdaq Stockholm AB, is 0.06 SEK per Offer Share.

The company issues 376 719 780 shares. Company’s major shareholders, Capricorn Healthtech Fund, Kaikarhenni Oy and Ossi Haapaniemi with his related-party companies, and the Company’s management team and certain Board members are, subject to certain terms and conditions, committed to subscribing for approximately 28% of the Offer Shares of the amount of approximately EUR 0.634 million.

Read the full Nexstim press release about this event